Thomas D. Salus

CIK: 0002062209

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)1 (16.7%)

Derivative conversions

Awards (A)3 (50.0%)

Compensation grants

Other (G, F, J, C, D, …)2 (33.3%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

$LIFECORE BIOMEDICAL, INC. \DE\ logo$

LFCR

LIFECORE BIOMEDICAL, INC. \DE\

Officer

Discretionary Trading P&L

Holdings

Transaction History (6 total)

$LIFECORE BIOMEDICAL, INC. \DE\ logo$
LFCR
LIFECORE BIOMEDICAL, INC. \DE\
Apr 14, 2026
Tax Payment(F)
Direct
24.6K shares at avg. $5.20$128K
$LIFECORE BIOMEDICAL, INC. \DE\ logo$
LFCR
LIFECORE BIOMEDICAL, INC. \DE\
Mar 2, 2026
Award(A)
Direct
30K shares-
$LIFECORE BIOMEDICAL, INC. \DE\ logo$
LFCR
LIFECORE BIOMEDICAL, INC. \DE\
Jul 8, 2025
Exercise(M)
Direct
37K shares-
$LIFECORE BIOMEDICAL, INC. \DE\ logo$
LFCR
LIFECORE BIOMEDICAL, INC. \DE\
Jul 8, 2025
Tax Payment(F)
Direct
11K shares at avg. $8.19$90K
$LIFECORE BIOMEDICAL, INC. \DE\ logo$
LFCR
LIFECORE BIOMEDICAL, INC. \DE\
Apr 14, 2025
Award(A)
Direct
45K shares-
$LIFECORE BIOMEDICAL, INC. \DE\ logo$
LFCR
LIFECORE BIOMEDICAL, INC. \DE\
Apr 14, 2025
Award(A)
Direct
170K shares-

		Type	Shares	Price		Ownership
Apr 14, 2026	$LIFECORE BIOMEDICAL, INC. \DE\ logo$ LFCR LIFECORE BIOMEDICAL, INC. \DE\	Tax Payment(F)	24,645	$5.20	$128,154	Direct
Mar 2, 2026	$LIFECORE BIOMEDICAL, INC. \DE\ logo$ LFCR LIFECORE BIOMEDICAL, INC. \DE\	Award(A)	30,000	-	$0	Direct
Jul 8, 2025	$LIFECORE BIOMEDICAL, INC. \DE\ logo$ LFCR LIFECORE BIOMEDICAL, INC. \DE\	Exercise(M)	37,000	-	-	Direct
Jul 8, 2025	$LIFECORE BIOMEDICAL, INC. \DE\ logo$ LFCR LIFECORE BIOMEDICAL, INC. \DE\	Tax Payment(F)	11,022	$8.19	$90,270	Direct
Apr 14, 2025	$LIFECORE BIOMEDICAL, INC. \DE\ logo$ LFCR LIFECORE BIOMEDICAL, INC. \DE\	Award(A)	45,000	-	-	Direct
Apr 14, 2025	$LIFECORE BIOMEDICAL, INC. \DE\ logo$ LFCR LIFECORE BIOMEDICAL, INC. \DE\	Award(A)	170,000	-	-	Direct

1-6 of 6 transactions

About Salus Thomas D.

Salus Thomas D. (SEC CIK 0002062209) files insider reports with the SEC as Chief Legal & Administration of LIFECORE BIOMEDICAL, INC. \DE\ (LFCR).

Signal8 holds 5 ownership filings by Salus Thomas D. (1 Form 3, 4 Form 4), filed between Apr 16, 2025 and Apr 16, 2026. Those filings report 6 transactions, from Apr 14, 2025 to Apr 14, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Salus Thomas D.'s filings is in CHASKA, MN.

Recent filings by Salus Thomas D.

Apr 14, 2026: Tax withholding of LFCR shares (Form 4, code F).
Mar 2, 2026: Grant or award of LFCR shares (Form 4, code A).
Jul 8, 2025: Option exercise of LFCR shares (Form 4, code M).
Jul 8, 2025: Tax withholding of LFCR shares (Form 4, code F).
Apr 14, 2025: Grants or awards of LFCR shares (2 lines, Form 4, code A).

Other insiders filing for LIFECORE BIOMEDICAL, INC. \DE\ (LFCR)

How to read Form 4 transaction codes